Discontinued — last reported Q4 '25
Over 4 years (FY 2021 to FY 2025), Impairment Charges shows a downward trend with a -100.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High impairment charges suggest poor capital allocation or a decline in the competitive value of the company's assets.
Impairment charges are non-cash write-downs taken when the carrying value of an asset exceeds its fair market value. Thi...
Common in industries with high intangible asset bases, such as pharma and consumer goods.
impairment_charges_cf| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.06B | $903.00M | $177.00M | $0.00 | $0.00 |
| YoY Change | — | -14.8% | -80.4% | -100.0% | — |